Market News
Jan. 24, 2017 TSE Designation of Securities Under Supervision (Confirmation) : T&C MEDICAL SCIENCE, INC.
TSE has designated an issue as Securities Under Supervision (Confirmation) as follows.
| １．Issue Name | T&C MEDICAL SCIENCE, INC. stock (Code: 3832, Market Division: JASDAQ Growth) |
| ２．Criteria pertaining to Business Performance | |
| （１）Period of Designation as Securities Under Supervision (Confirmation) | From Jan. 24, 2017 (Tue.) until the date when TSE determines whether such issue meets the delisting criteria. |
| Provision | Enforcement Rules for Securities Listing Regulations Rule 605, Paragraph 1, Item 25-3 (Due to a case where a listed company has made an announcement that it is in the state defined by Rule 604-2, Paragraph 1, Item 2 of the Securities Listing Regulations (meaning cases pursuant to Rule 604-4, Paragraph 1, Item 1 of the aforementioned regulations), etc. but where the Exchange cannot determine whether the company meets such provisions) |
| （２）Reason | T&C MEDICAL SCIENCE, INC. (hereinafter "the Company") has been placed in a grace period pertaining to delisting, because the operating income and cash flow due to business activities for the four most recent consolidated accounting years (the fiscal year ended Nov. 2012 through the fiscal year ended Nov. 2015) were negative. The Company announced today that it expects the operating income and cash flow due to business activities for the fiscal year ended Nov. 2016 to be negative. In the event that TSE confirms, based on documents including the securities report submitted by the Company, that the operating income and cash flow due to business activities for the five most recent consolidated accounting years (the fiscal year ended Nov. 2012 through the fiscal year ended Nov. 2016) is negative, the Company's stock will be delisted. As such, TSE deems that said stock is likely to be delisted based on the Company's announcement. Therefore, TSE designates said stock as Securities Under Supervision (Confirmation). |
| ３．Criteria pertaining to Liabilities in Excess of Assets | |
| （１）Period of Designation as Securities Under Supervision (Confirmation) | From Jan. 24, 2017 (Tue.) until the date when TSE determines whether such issue meets the delisting criteria. |
| Provision | Enforcement Rules for Securities Listing Regulations Rule 605, Paragraph 1, Item 7 (Due to a case where a listed company has made an announcement that it is in the state defined by Rule 601, Paragraph 1, Item 5 of the Securities Listing Regulations (meaning cases pursuant to Rule 604-4, Paragraph 1, Item 2 of the aforementioned regulations), etc. but where the Exchange cannot determine whether the company meets such provisions) |
| （２）Reason | The Company had been placed in a grace period pertaining to delisting, because the Company had liabilities in excess of assets at the time of account settlement for the fiscal year ended Nov. 2015. The Company announced today that it expects to have liabilities in excess of assets once again at the time of account settlement for the fiscal year ended Nov. 2016. In the event that TSE determines that the Company has liabilities in excess of assets at the time of account settlement for said fiscal year upon inspection of the Company's consolidated balance sheet in the securities report, the Company's stock will be delisted. As such, TSE deems that said stock is likely to be delisted based on the Company's announcement. Therefore, TSE designates said stock as Securities Under Supervision (Confirmation). |
Current Designations of Securities Under Supervision & Securities to Be Delisted
Designation History of Securities Under Supervision & Securities to Be Delisted
Designation History of Securities Under Supervision & Securities to Be Delisted
DISCLAIMER: This translation may be used for reference purposes only. This English version is not an official translation of the original Japanese document. In cases where any differences occur between the English version and the original Japanese version, the Japanese version shall prevail. This translation is subject to change without notice. Tokyo Stock Exchange, Inc. and/or Japan Exchange Regulation shall individually or jointly accept no responsibility or liability for damage or loss caused by any error, inaccuracy, misunderstanding, or changes with regard to this translation.
Enquiry
Tokyo Stock Exchange, Inc. Listing Department, Listed Company Administration, Listed Company Services
TEL:+81-3-3666-0141(Switchboard)